Several studies have confirmed the expression of AMHRII in gynecological cancer tissues [13,14,15,16,17] and pro-apoptotic/growth inhibition activity of AMH was repeatedly described in ovarian, cervical, and endometrial cancer cells, confirming the potential of AMHRII as a target for anticancer agents [18,19]. Here, AMH is linked to female reproductive organ cancer.